Substituted furo (2,3-b) pyridine derivatives

Details for Australian Patent Application No. 2003257145 (hide)

Owner Merck & Co., Inc.

Inventors Madsen-Duggan, Christina B.; Debenham, John S.; Walsh, Thomas F.; Goulet, Mark T.; Toupence, Richard B.; Shah, Shrenik K.

Agent Spruson & Ferguson

Pub. Number AU-B-2003257145

PCT Number PCT/US03/24280

PCT Pub. Number WO2004/012671

Priority 60/456,332 20.03.03 US; 60/400,852 02.08.02 US

Filing date 1 August 2003

Wipo publication date 23 February 2004

Acceptance publication date 13 November 2008

International Classifications

C07D 491/048 (2006.01) Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or

A61K 31/00 (2006.01)

A61K 31/4355 (2006.01)

A61K 31/4375 (2006.01)

A61K 31/444 (2006.01)

A61K 31/4545 (2006.01)

A61K 31/496 (2006.01) - Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene

A61K 31/5377 (2006.01)

A61P 1/00 (2006.01) Drugs for disorders of the alimentary tract or the digestive system

A61P 1/10 (2006.01) Drugs for disorders of the alimentary tract or the digestive system

A61P 1/16 (2006.01) Drugs for disorders of the alimentary tract or the digestive system

A61P 3/04 (2006.01) Drugs for disorders of the metabolism

A61P 9/10 (2006.01) Drugs for disorders of the cardiovascular system

A61P 11/06 (2006.01) Drugs for disorders of the respiratory system

A61P 25/00 (2006.01) Drugs for disorders of the nervous system

A61P 25/06 (2006.01) Drugs for disorders of the nervous system

A61P 25/08 (2006.01) Drugs for disorders of the nervous system

A61P 25/16 (2006.01) Drugs for disorders of the nervous system

A61P 25/18 (2006.01) Drugs for disorders of the nervous system

A61P 25/20 (2006.01) Drugs for disorders of the nervous system

A61P 25/22 (2006.01) Drugs for disorders of the nervous system

A61P 25/28 (2006.01) Drugs for disorders of the nervous system

A61P 25/30 (2006.01) Drugs for disorders of the nervous system

A61P 43/00 Drugs for specific purposes, not provided for in groups

Event Publications

6 November 2003 Complete Application Filed

  Priority application(s): 60/456,332 20.03.03 US; 60/400,852 02.08.02 US

1 April 2004 Application Open to Public Inspection

  Published as AU-B-2003257145

13 November 2008 Application Accepted

  Published as AU-B-2003257145

12 March 2009 Standard Patent Sealed

21 January 2010 Amendment Made

  The nature of the amendment is: Amend the patentee name from Merck & Co., Inc. to Merck Sharp & Dohme Corp.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003257146-METHODS AND APPARATUS FOR NETWORK SIGNAL AGGREGATION AND BANDWIDTH REDUCTION

2003257144-FLEXIBLE, INSULATIVE FIRE PROTECTIVE COATINGS AND CONDUITS, UTILITARIAN COMPONENTS, AND STRUCTURAL MATERIALS COATED THEREWITH